Saba Capital Management, L.P. - THE ONCOLOGY INSTITUTE INC ownership

THE ONCOLOGY INSTITUTE INC's ticker is and the CUSIP is 68236X100. A total of 41 filers reported holding THE ONCOLOGY INSTITUTE INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Saba Capital Management, L.P. ownership history of THE ONCOLOGY INSTITUTE INC
ValueSharesWeighting
Q3 2023$131,970
+40.8%
94,264
-44.7%
0.00%
+50.0%
Q2 2023$93,742
-20.8%
170,378
-2.4%
0.00%0.0%
Q1 2023$118,302
-58.9%
174,5130.0%0.00%
-50.0%
Q4 2022$287,946
-82.1%
174,513
-49.9%
0.00%
-77.8%
Q3 2022$1,612,000
-13.2%
348,059
-5.2%
0.02%
-18.2%
Q2 2022$1,858,000
-34.9%
367,292
-8.2%
0.02%
-46.3%
Q1 2022$2,852,000
-23.6%
400,0000.0%0.04%
-26.8%
Q4 2021$3,732,000400,0000.06%
Other shareholders
THE ONCOLOGY INSTITUTE INC shareholders Q4 2022
NameSharesValueWeighting ↓
Parian Global Management LP 444,244$3,167,0006.52%
Velan Capital Investment Management LP 600,000$4,278,0003.97%
Triatomic Management LP 428,100$3,052,0002.48%
Empery Asset Management, LP 70,733$504,0002.37%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,296,107$32,137,0000.72%
Redmile Group, LLC 2,414,432$17,215,0000.54%
Alpine Global Management, LLC 81,902$584,0000.07%
Saba Capital Management, L.P. 400,000$2,852,0000.04%
ExodusPoint Capital Management, LP 106,505$759,0000.01%
FMR LLC 12,000,000$85,560,0000.01%
View complete list of THE ONCOLOGY INSTITUTE INC shareholders